Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Charles River Laboratories International, Inc.
  6. Summary
    CRL   US1598641074

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(CRL)
  Report
Delayed Nyse  -  04:00 2022-07-01 pm EDT
218.83 USD   +2.27%
06/28Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
BU
06/28Charles River Laboratories International, Inc. Announces Opening of U.K. Manufacturing Facility
CI
06/24CHARLES RIVER LABORATORIES INTERNATIONAL, INC.(NYSE : CRL) dropped from Russell 1000 Growth-Defensive Index
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
225.49(c) 217.5(c) 219.46(c) 213.97(c) 218.83(c) Last
355 390 320 335 381 197 596 926 275 655 Volume
-0.37% -3.54% +0.90% -2.50% +2.27% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 4 026 M - -
Net income 2022 450 M - -
Net Debt 2022 2 232 M - -
P/E ratio 2022 25,4x
Yield 2022 -
Sales 2023 4 466 M - -
Net income 2023 579 M - -
Net Debt 2023 1 756 M - -
P/E ratio 2023 19,9x
Yield 2023 -
Capitalization 11 118 M 11 118 M -
EV / Sales 2022 3,32x
EV / Sales 2023 2,88x
Nbr of Employees 19 300
Free-Float 98,8%
More Financials
Company
More about the company
Ratings of Charles River Laboratories International, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
06/28Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
BU
06/28Charles River Laboratories International, Inc. Announces Opening of U.K. Manufacturing ..
CI
06/24CHARLES RIVER LABORATORIES INTERNATI : CRL) dropped from Russell 1000 Growth-Defensive Ind..
CI
06/24CHARLES RIVER LABORATORIES INTERNATI : CRL) dropped from Russell 1000 Value-Defensive Inde..
CI
06/24CHARLES RIVER LABORATORIES INTERNATI : CRL) dropped from Russell 1000 Defensive Index
CI
06/23Charles River Laboratories to Work With Ziphius Vaccines to Manufacture Starting Materi..
MT
06/23Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
BU
06/23Charles River Laboratories International, Inc. and Ziphius Vaccines NV Collaborates to ..
CI
06/13Charles River Laboratories Working With ASC Therapeutics to Manufacture Hemophilia A Dr..
MT
06/13Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene The..
BU
06/13Charles River Laboratories International, Inc. and ASC Therapeutics, Inc. to Scale Manu..
CI
06/09TRANSCRIPT : Charles River Laboratories International, Inc. Presents at William Blair’..
CI
06/08Moderna, Roku rise; Scotts Miracle-Gro, Charles River fall
AQ
06/08TRANSCRIPT : Charles River Laboratories International, Inc. Presents at 2022 Jefferies Glo..
CI
06/08CHARLES RIVER LABORATORIES INTERNATI : Regulation FD Disclosure - Form 8-K
PU
More news
News in other languages on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
06/28Charles River Laboratories International, Inc. annonce l'ouverture d'un site de fabrica..
06/23Les Laboratoires Charles River vont collaborer avec Ziphius Vaccines pour fabriquer des..
06/23Charles River Laboratories International, Inc. et Ziphius Vaccines NV collaborent pour ..
06/13Les Laboratoires Charles River collaborent avec ASC Therapeutics pour la fabrication d'..
06/13Charles River Laboratories International, Inc. et ASC Therapeutics, Inc. vont mettre à ..
More news
Analyst Recommendations on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
More recommendations
Analysis
Western businesses cut some Russia ties over Ukraine invasion
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Duration : Period :
Charles River Laboratories International, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 218,83 $
Average target price 326,85 $
Spread / Average Target 49,4%
EPS Revisions
Managers and Directors
James C. Foster General Counsel
Flavia H. Pease Chief Financial Officer & Executive Vice President
Arthur C. Hubbs Chief Information Officer & Senior Vice President
Birgit Girshick Chief Operating Officer & Executive Vice President
Matthew L. Daniel Senior Corporate Counsel
Sector and Competitors
1st jan.Capi. (M$)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.-41.92%11 118
MODERNA, INC.-40.96%59 644
IQVIA HOLDINGS INC.-23.78%40 704
LONZA GROUP AG-31.83%40 011
SEAGEN INC.16.50%33 154
CELLTRION, INC.-9.60%19 031